rs4792008

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002470.4(MYH3):​c.4956+32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,604,222 control chromosomes in the GnomAD database, including 377,489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 27810 hom., cov: 33)
Exomes 𝑓: 0.69 ( 349679 hom. )

Consequence

MYH3
NM_002470.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0540

Publications

9 publications found
Variant links:
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-10632444-G-A is Benign according to our data. Variant chr17-10632444-G-A is described in ClinVar as Benign. ClinVar VariationId is 258690.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH3NM_002470.4 linkc.4956+32C>T intron_variant Intron 34 of 40 ENST00000583535.6 NP_002461.2 P11055Q5GJ67

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH3ENST00000583535.6 linkc.4956+32C>T intron_variant Intron 34 of 40 5 NM_002470.4 ENSP00000464317.1 P11055
MYHASENST00000579914.2 linkn.705+18567G>A intron_variant Intron 4 of 4 4
MYHASENST00000584139.2 linkn.1041+18567G>A intron_variant Intron 7 of 8 3
MYHASENST00000781814.1 linkn.165-2241G>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.573
AC:
87100
AN:
152014
Hom.:
27808
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.296
Gnomad AMI
AF:
0.743
Gnomad AMR
AF:
0.561
Gnomad ASJ
AF:
0.703
Gnomad EAS
AF:
0.369
Gnomad SAS
AF:
0.524
Gnomad FIN
AF:
0.706
Gnomad MID
AF:
0.548
Gnomad NFE
AF:
0.733
Gnomad OTH
AF:
0.589
GnomAD2 exomes
AF:
0.607
AC:
148956
AN:
245230
AF XY:
0.620
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.467
Gnomad ASJ exome
AF:
0.707
Gnomad EAS exome
AF:
0.362
Gnomad FIN exome
AF:
0.714
Gnomad NFE exome
AF:
0.727
Gnomad OTH exome
AF:
0.652
GnomAD4 exome
AF:
0.686
AC:
995503
AN:
1452090
Hom.:
349679
Cov.:
33
AF XY:
0.684
AC XY:
494676
AN XY:
722910
show subpopulations
African (AFR)
AF:
0.277
AC:
9241
AN:
33372
American (AMR)
AF:
0.479
AC:
21435
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.704
AC:
18395
AN:
26112
East Asian (EAS)
AF:
0.367
AC:
14568
AN:
39682
South Asian (SAS)
AF:
0.540
AC:
46541
AN:
86142
European-Finnish (FIN)
AF:
0.719
AC:
34287
AN:
47664
Middle Eastern (MID)
AF:
0.563
AC:
2943
AN:
5224
European-Non Finnish (NFE)
AF:
0.729
AC:
808831
AN:
1109004
Other (OTH)
AF:
0.652
AC:
39262
AN:
60184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
15752
31505
47257
63010
78762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19642
39284
58926
78568
98210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.573
AC:
87125
AN:
152132
Hom.:
27810
Cov.:
33
AF XY:
0.568
AC XY:
42234
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.295
AC:
12254
AN:
41496
American (AMR)
AF:
0.561
AC:
8581
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.703
AC:
2442
AN:
3472
East Asian (EAS)
AF:
0.371
AC:
1917
AN:
5174
South Asian (SAS)
AF:
0.523
AC:
2524
AN:
4822
European-Finnish (FIN)
AF:
0.706
AC:
7470
AN:
10578
Middle Eastern (MID)
AF:
0.545
AC:
159
AN:
292
European-Non Finnish (NFE)
AF:
0.733
AC:
49855
AN:
67984
Other (OTH)
AF:
0.589
AC:
1245
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1638
3275
4913
6550
8188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.653
Hom.:
15053
Bravo
AF:
0.547
Asia WGS
AF:
0.448
AC:
1564
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Freeman-Sheldon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Arthrogryposis, distal, type 2B3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.8
DANN
Benign
0.73
PhyloP100
0.054
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4792008; hg19: chr17-10535761; COSMIC: COSV56865868; COSMIC: COSV56865868; API